Literature DB >> 19903423

Insights into IBD Pathogenesis.

David Q Shih1, Stephan R Targan.   

Abstract

Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disorder caused by dysregulated immune responses in a genetically predisposed individual. Recent accumulating data, including genome-wide association studies, have identified more than 50 distinct genetic loci that confer susceptibility. We highlight the role of microbial-host interaction, particularly with respect to the overlap of common genetic and pathophysiologic mechanisms of CD and UC, interleukin-22-producing natural killer cells, autophagy, and TL1A, a member of the tumor necrosis factor (TNF) family, in gut homeostasis and IBD pathogenesis. This article focuses on the recent advances in understanding of IBD from the past year, including advances in genetics and immunobiology.

Entities:  

Mesh:

Year:  2009        PMID: 19903423      PMCID: PMC2895981          DOI: 10.1007/s11894-009-0072-9

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  50 in total

1.  Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease.

Authors:  Keiko Yamazaki; Dermot McGovern; Jiannis Ragoussis; Marta Paolucci; Helen Butler; Derek Jewell; Lon Cardon; Masakazu Takazoe; Torao Tanaka; Toshiki Ichimori; Susumu Saito; Akihiro Sekine; Aritoshi Iida; Atsushi Takahashi; Tatsuhiko Tsunoda; Mark Lathrop; Yusuke Nakamura
Journal:  Hum Mol Genet       Date:  2005-10-12       Impact factor: 6.150

2.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

3.  Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease.

Authors:  Y Kakuta; Y Kinouchi; K Negoro; S Takahashi; T Shimosegawa
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

4.  Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis.

Authors:  Andre Franke; Tobias Balschun; Tom H Karlsen; Jürgen Hedderich; Sandra May; Tim Lu; Dörthe Schuldt; Susanna Nikolaus; Philip Rosenstiel; Michael Krawczak; Stefan Schreiber
Journal:  Nat Genet       Date:  2008-04-27       Impact factor: 38.330

5.  Human IRGM induces autophagy to eliminate intracellular mycobacteria.

Authors:  Sudha B Singh; Alexander S Davis; Gregory A Taylor; Vojo Deretic
Journal:  Science       Date:  2006-08-03       Impact factor: 47.728

6.  Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.

Authors:  Marc Veldhoen; Richard J Hocking; Richard A Flavell; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2006-09-24       Impact factor: 25.606

7.  Arachidonate release and eicosanoid generation by group IIE phospholipase A(2).

Authors:  Makoto Murakami; Kumiko Yoshihara; Satoko Shimbara; Gerard Lambeau; Alan Singer; Michael H Gelb; Masatsugu Sawada; Naoki Inagaki; Hiroichi Nagai; Ichiro Kudo
Journal:  Biochem Biophys Res Commun       Date:  2002-04-05       Impact factor: 3.575

8.  Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.

Authors:  David A van Heel; Subrata Ghosh; Matt Butler; Karen A Hunt; Anna M C Lundberg; Tariq Ahmad; Dermot P B McGovern; Clive Onnie; Kenichi Negoro; Sue Goldthorpe; Brian M J Foxwell; Christopher G Mathew; Alastair Forbes; Derek P Jewell; Raymond J Playford
Journal:  Lancet       Date:  2005 May 21-27       Impact factor: 79.321

9.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Authors:  Daniel J Cua; Jonathan Sherlock; Yi Chen; Craig A Murphy; Barbara Joyce; Brian Seymour; Linda Lucian; Wayne To; Sylvia Kwan; Tatyana Churakova; Sandra Zurawski; Maria Wiekowski; Sergio A Lira; Daniel Gorman; Robert A Kastelein; Jonathon D Sedgwick
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

10.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

View more
  32 in total

1.  Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis.

Authors:  Robert Barrett; Xiaolan Zhang; Hon Wai Koon; Michelle Vu; Jyh-Yau Chang; Nicole Yeager; Mary Ann Nguyen; Kathrin S Michelsen; Dror Berel; Charalabos Pothoulakis; Stephan R Targan; David Q Shih
Journal:  Am J Pathol       Date:  2011-12-02       Impact factor: 4.307

2.  Distinct and overlapping genetic loci in Crohn's disease and ulcerative colitis: correlations with pathogenesis.

Authors:  Matti Waterman; Wei Xu; Joanne M Stempak; Raquel Milgrom; Charles N Bernstein; Anne M Griffiths; Gordon R Greenberg; A Hillary Steinhart; Mark S Silverberg
Journal:  Inflamm Bowel Dis       Date:  2010-12-10       Impact factor: 5.325

3.  Black tea polyphenol theaflavin suppresses LPS-induced ICAM-1 and VCAM-1 expression via blockage of NF-κB and JNK activation in intestinal epithelial cells.

Authors:  Young-A Song; Young-Lan Park; Sun-Hye Yoon; Kyu-Yeol Kim; Sung-Bum Cho; Wan-Sik Lee; Ik-Joo Chung; Young-Eun Joo
Journal:  Inflamm Res       Date:  2010-12-24       Impact factor: 4.575

4.  Microbiota-sensitive epigenetic signature predicts inflammation in Crohn's disease.

Authors:  Daniel Kelly; Michael Kotliar; Vivienne Woo; Sajjeev Jagannathan; Jordan Whitt; Jessica Moncivaiz; Bruce J Aronow; Marla C Dubinsky; Jeffrey S Hyams; James F Markowitz; Robert N Baldassano; Michael C Stephens; Thomas D Walters; Subra Kugathasan; Yael Haberman; Nambirajan Sundaram; Michael J Rosen; Michael Helmrath; Rebekah Karns; Artem Barski; Lee A Denson; Theresa Alenghat
Journal:  JCI Insight       Date:  2018-09-20

5.  The nucleotide synthesis enzyme CAD inhibits NOD2 antibacterial function in human intestinal epithelial cells.

Authors:  Amy L Richmond; Amrita Kabi; Craig R Homer; Noemí Marina-García; Kourtney P Nickerson; Alexey I Nesvizhskii; Arun Sreekumar; Arul M Chinnaiyan; Gabriel Nuñez; Christine McDonald
Journal:  Gastroenterology       Date:  2012-02-28       Impact factor: 22.682

Review 6.  Immune responses triggering colitis and colitis-associated carcinoma.

Authors:  Rebecca Kesselring; Stefan Fichtner-Feigl
Journal:  Langenbecks Arch Surg       Date:  2012-03-01       Impact factor: 3.445

Review 7.  Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.

Authors:  Guillaume Bouguen; Jean-Baptiste Chevaux; Laurent Peyrin-Biroulet
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 8.  Future therapeutic approaches for inflammatory bowel diseases.

Authors:  Scott E Plevy; Stephan R Targan
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

9.  Substance P modulates colitis-associated fibrosis.

Authors:  Hon Wai Koon; David Shih; Iordanes Karagiannides; Dezheng Zhao; Zafeer Fazelbhoy; Tressia Hing; Hua Xu; Bao Lu; Norma Gerard; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

Review 10.  Intestinal barrier in inflammatory bowel disease.

Authors:  Lena Antoni; Sabine Nuding; Jan Wehkamp; Eduard F Stange
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.